Skip to main content
  • Correspondence
  • Open access
  • Published:

Letter to the editor regarding “Covid-19 transmission in fitness centers in Norway - a randomized trial”

A Correspondence to this article was published on 27 December 2022

The Original Article was published on 16 November 2021

Abstract

In a recently published paper in BMC Public Health we read about a randomized trial on Covid-19 transmission performed in five fitness centers in Oslo, Norway, during the spring of 2020. In our opinion, this study has major shortcomings in design and methodology, which have not been addressed by the authors.

Peer Review reports

Background

In a recently published paper in BMC Public Health we read about a randomized trial on Covid-19 transmission performed in five fitness centers in Oslo, Norway, during the spring of 2020 [1]. In our opinion, this study has major shortcomings in design and methodology, which have not been addressed by the authors.

Main text

The most obvious problem with the study is the low Covid-19 incidence in the trial, which reflects the low number of infections in Oslo at the time [2]. Regardless of the reasons for the low level of infection, there is no real value of randomization when the number of infectious individuals is very low, and the trial duration is a short pre-specified interval. With a near absence of infection in the study population, it should also be clear that generalizability to other levels of infection is not possible.

Another problem with the study is that it largely disregards that Covid-19 is an infectious disease. Infection, by definition, happens within groups of individuals and populations. In this study, this could mean within fitness centers, or groups of individuals training together at the centers or even outside the centers. These dependencies should have been taken into account at both the design and analysis stage. Simulation studies have been suggested for informing proper design and sample size calculations in these settings [3].

Other problems particular to trials for non-pharmaceutical interventions (NPIs) for infectious diseases due to non-blinding and interference, e.g. that the treatment of one subject can affect the outcome of another [3, 4], are also ignored and not discussed. Furthermore, the authors do not argue for the relevance of the intention to treat (ITT) effect under the present drop-out and non-compliance rates. This is a non-inferiority trial, for which it is known that the ITT principle can be problematic [5].

Even if the trial had not been underpowered and conducted without any of the other problems above, it is unclear how the results of a trial like this can be generalized to fitness centers in a non-experimental setting, let alone to other settings with, for example, different disease prevalence, virus strain, level of immunity, season and other simultaneous NPIs in the wider population. How such trials should guide future policy is therefore not obvious.

Conclusions

To perform appropriate studies of the effects of NPIs for infectious diseases, that can guide future policy making, the challenges in both study design and causal inference from such studies cannot be ignored. As it has been argued by others, naïvely designed trials can be worse than uninformative, they can be misinformative [6]. The authors conclude that their study "show that it is feasible to apply rigorous randomized testing of public health measures during an ongoing disease outbreak", but we come to another conclusion. What we should learn from this study is that rigorous randomized testing of public health measures during an ongoing infectious disease outbreak is not trivial and should not be approached as a trivial task.

Availability of data and material

Not applicable.

Abbreviations

ITT:

Intention to treat

NPI:

Non-pharmaceutical intervention

References

  1. Helsingen LM, Løberg M, Refsum E, Gjøstein DK, Wieszczy P, Olsvik Ø, et al. Covid-19 transmission in fitness centers in Norway-a randomized trial. BMC Public Health. 2021;21(1):1–9. https://doi.org/10.1186/s12889-021-12073-0.

    Article  CAS  Google Scholar 

  2. Norwegian Institute of Public Health 2020. Covid-19 weekly report. Available from: https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/vedlegg/forste-halvar-2020/2020-06-10-ukerapport-uke-23-covid-19_v2.pdf. Accessed 16 June 2022.

  3. Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, et al. Simulations for designing and interpreting intervention trials in infectious diseases. BMC Med. 2017;15(1):1–8. https://doi.org/10.1186/s12916-017-0985-3.

    Article  Google Scholar 

  4. VanderWeele TJ, Tchetgen EJT, Halloran ME. Interference and sensitivity analysis. Stat Sci. 2014;29(4):687–706. https://doi.org/10.1214/14-STS479.

    Article  Google Scholar 

  5. Hernán MA, Hernández-Díaz S. Beyond the intention-to-treat in comparative effectiveness research. Clin Trials. 2012;9(1):48–55. https://doi.org/10.1177/1740774511420743.

    Article  Google Scholar 

  6. Haber NA, Wieten SE, Smith ER, Nunan D. Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?” Trials. 2021;22(1):1–4. https://doi.org/10.1186/s13063-021-05755-y.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

No funding was received for this Letter to the Editor.

Author information

Authors and Affiliations

Authors

Contributions

MV, JMG and ML drafted the first version of this letter. MV, JMG, CSR and ML critically revised the manuscript. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Morten Valberg.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Marissa LeBlanc declares a paid speaking engagement for MSD unrelated to the content of this work. The remaining authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valberg, M., Gran, J.M., Rueegg, C.S. et al. Letter to the editor regarding “Covid-19 transmission in fitness centers in Norway - a randomized trial”. BMC Public Health 22, 2433 (2022). https://doi.org/10.1186/s12889-022-14800-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-022-14800-7

Keywords